Acyclovir

Producers shown on SFDA

(Record date:31/08/2021）

Producers shown on EP

Not showing any

Producer:Zhejiang Zhebei Pharmaceutical Co., Ltd., formerly known as Zhebei pharmaceutical factory, was established in 1989. It is a professional pharmaceutical factory specializing in the production of nucleoside antiviral and cardiovascular drugs. The company has three production bases, mainly producing pharmaceutical raw materials, APIs and preparations.

The pharmaceutical preparation production base is located in sanlitang, Qianyuan Town, Deqing County. It is also the registered place and headquarters of the company, including two production workshops, of which the tablet workshop has an annual production capacity of 300 million tablets; The annual production capacity of oral liquid workshop is 50 million; The raw material drug production base is located at No. 66, guoshantou, Xinshi Town, Deqing County. It has a production workshop with an annual production capacity of 250 tons.

Staff size:100-199 persons

Registered capital:RMB 50 million

Producer:Hubei Yitai Pharmaceutical Co., LTD. is a professional APIs  and food additives manufacturer. The company was founded in 2000 with a registered capital of 99.9 million RMB. After more than ten years of development, the total assets have reached to 400 million RMB. The total number of employees is 600. Among them, more than 30% are technicians from more than 10 provinces and cities. The company covers an area of 333000 m2, and the green area accounts for more than 35% of the total area.

Staff size:About 600 persons

Registered capital:RMB 106.566666 million 

Producer:Zhejiang Charioteer Pharmaceutical Co., Ltd. , founded in 1988, is a professional manufacturer of nucleoside antiviral series, anti-inflammatory and analgesic series and other APIs. It is committed to the sales and service in the international regulatory market. Its main products have passed the FDA certification of the United States and the cos certification of Europe. All products have obtained the national GMP certificate. In 2004, it passed ISO9001, ISO14001 and OHSAS18001 management system certification.

Staff size:About 1500 persons

Registered capital:RMB 84 million 375 thousand

Producer:Changzhou Kony Pharmaceutical Co., Ltd.Founded in 1986, Shanghai Pharmaceutical Kangli (Changzhou) Pharmaceutical Co., Ltd. is a professional manufacturer of APIs and pharmaceutical intermediates. In 2012, it became a member enterprise of Shanghai Pharmaceutical Group, covering an area of 65000 square meters, with fixed assets of more than 50 million yuan and more than 240 employees, of which scientific and technological personnel account for 20%.

The company organizes production in strict accordance with GMP, has complete production and scientific research equipment, has a number of imported advanced testing equipment, has stable product quality, is exported to Southeast Asia and developed countries and regions, and enjoys a high reputation among customers at home and abroad.

 Staff size:200-299 persons

Registered capital:RMB 14.94638 million

Producer:Xinxiang pharmaceutical Co., Ltd. is a national second-largest comprehensive drug manufacturer., Covering an area of 130000 square meters, it has domestic advanced production equipment, perfect product testing means and quality assurance system. It has developed from a single variety in the past to 50 varieties in four series. It has the advantages of independent development, modern production and standardized quality inspection. The company passed GMP certification in 2004. A variety of its products have reached the standards of the United States Pharmacopoeia (USP) and the European Pharmacopoeia (EP). The products are exported to more than 20 countries and regions such as America, Europe, Southeast Asia, East Asia and Africa, and have initially formed an international marketing network.

 Staff size:600-699 persons

Registered capital:RMB 50 million

Producer:Suzhou Homesun Pharmaceutical Co., Ltd. was established on April 17, 2009, production address: Jiangsu Taicang Port Development Zone, petrochemical zone GCL Road on the 12th, registered capital of 98 million yuan, 2.3 million yuan in fixed assets, covers an area of 4.3 million square meters, construction area of 2.5 million square meters.

Company's main products include pharmaceutical intermediates, pharmaceutical raw materials (including sterile APIs), frozen dried powder injection, small volume injection, oral solid dosage forms (tablets and capsules) and inhalation solution. Currently has 17 APIs and small capacity injection workshop, tablets, hard capsule agent through the national GMP certification, with an annual output of: 350 tons of raw material medicine (fine baked package), 1 billion ampoules of small volume injections, 15 million tablets, 1 million capsules agent, product coverage of antitumor, antiviral, central nervous, anti infective, cardiovascular, digestive, antipyretic analgesic class.

Staff size:About 150 persons

Registered capital:RMB98 million 

Producer:Zhejiang Chengyi Pharmaceutical Co.,Ltd. was founded in 1966 and is now a comprehensive modern pharmaceutical enterprise specializing in the production of capsules, injections, tablets, APIs and pharmaceutical intermediates. It landed on the main board of Shanghai Stock Exchange on March 15, 2017.

The company can produce more than 60 varieties and nearly 100 specifications of drugs. All products have passed the national GMP certification, and many products have passed the certification of FDA, EMEA, TGA, MHRA, cofepris and other countries and regions.

Staff size:About 700 persons

Registered capital:RMB 233 million 800 thousand

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978